These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 30732926)

  • 1. Re: Rano Matta, Christopher J.D. Wallis, Mitchell G. Goldenberg, et al. Variation and Trends in Antidepressant Prescribing for Men Undergoing Treatment for Nonmetastatic Prostate Cancer: A Population-based Cohort Study. Eur Urol 2019;75:3-7: Translational Potential of Dual Detection: Depression Diagnosis plus Sense of Coherence Determination in Prostate Cancer.
    Vale S
    Eur Urol; 2019 Jun; 75(6):e168-e169. PubMed ID: 30732926
    [No Abstract]   [Full Text] [Related]  

  • 2. Variation and Trends in Antidepressant Prescribing for Men Undergoing Treatment for Nonmetastatic Prostate Cancer: A Population-based Cohort Study.
    Matta R; Wallis CJD; Goldenberg MG; Hird AE; Klaassen Z; Kulkarni G; Kodama RT; Herschorn S; Nam RK
    Eur Urol; 2019 Jan; 75(1):3-7. PubMed ID: 30241972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re: Christopher J.D. Wallis, Refik Saskin, Richard Choo, et al. Surgery Versus Radiotherapy for Clinically-localized Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol 2016;70:21-30.
    Blanchard P; Briganti A; Bossi A
    Eur Urol; 2016 Jul; 70(1):e15-e16. PubMed ID: 26922406
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: Christopher J.D. Wallis, Refik Saskin, Richard Choo, et al. Surgery Versus Radiotherapy for Clinically-localized Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol 2016;70:21-30.
    Parker C
    Eur Urol; 2016 Jul; 70(1):e17. PubMed ID: 26928379
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: Christopher J.D. Wallis, Refik Saskin, Richard Choo, et al. Surgery Versus Radiotherapy for Clinically-localized Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol 2016;70:21-30.
    Ost P; Ghadjar P
    Eur Urol; 2016 Jul; 70(1):e11-e12. PubMed ID: 26928380
    [No Abstract]   [Full Text] [Related]  

  • 6. Re: Christopher J.D. Wallis, Refik Saskin, Richard Choo, et al. Surgery Versus Radiotherapy for Clinically-localized Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol 2016;70:21-30.
    Froehner M; Wirth MP
    Eur Urol; 2016 Jul; 70(1):e9. PubMed ID: 26935557
    [No Abstract]   [Full Text] [Related]  

  • 7. Re: Christopher J.D. Wallis, Refik Saskin, Richard Choo, et al. Surgery Versus Radiotherapy for Clinically-localized Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol 2016;70:21-30.
    Tree AC; van As NJ; Dearnaley DP
    Eur Urol; 2016 Jul; 70(1):e10. PubMed ID: 26948396
    [No Abstract]   [Full Text] [Related]  

  • 8. Re: Christopher J.D. Wallis, Refik Saskin, Richard Choo, et al. Surgery Versus Radiotherapy for Clinically-localized Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol 2016;70:21-30: Radical Prostatectomy Versus Radiation for Clinically Localized Prostate Cancer: Two Systematic Reviews and a Randomized Controlled Trial.
    Lazar AA; Lizarraga TLC; Roach M
    Eur Urol; 2016 Jul; 70(1):e13-e14. PubMed ID: 26935558
    [No Abstract]   [Full Text] [Related]  

  • 9. Re: Karl H. Tully, David-Dan Nguyen, Peter Herzog, et al. Risk of Dementia and Depression in Young and Middle-aged Men Presenting with Nonmetastatic Prostate Cancer Treated with Androgen Deprivation Therapy. Eur Urol Oncol. In press. http://dx.doi.org/10.1016/j.euo.2019.08.003.
    Fragkoulis C; Glykas I; Papadopoulos G; Ntoumas K
    Eur Urol Oncol; 2020 Dec; 3(6):809-810. PubMed ID: 32156507
    [No Abstract]   [Full Text] [Related]  

  • 10. Re: Hendrik Van Poppel, Monique J. Roobol, Christopher R. Chapple, et al. Prostate-specific Antigen Testing as Part of a Risk-Adapted Early Detection Strategy for Prostate Cancer: European Association of Urology Position and Recommendations for 2021. Eur Urol 2021;80:703-711: Would You Play a Russian Roulette-type Game of Prostate-specific Antigen Screening on Yourself?
    Takahashi T
    Eur Urol; 2022 Jan; 81(1):e22. PubMed ID: 34716050
    [No Abstract]   [Full Text] [Related]  

  • 11. Re: Christopher E. Bayne, Stephen B. Williams, Matthew R. Cooperberg, et al. Treatment of the Primary Tumor in Metastatic Prostate Cancer: Current Concepts and Future Perspectives. Eur Urol 2016;69:775-87.
    Yang L; Qiu S; Wei Q
    Eur Urol; 2017 Feb; 71(2):e49-e50. PubMed ID: 27451134
    [No Abstract]   [Full Text] [Related]  

  • 12. Re: Declan G. Murphy, Christopher J. Sweeney, Bertrand Tombal. "Gotta Catch 'em All" or Do We? Pokemet Approach to Metastatic Prostate Cancer. Eur Urol 2017;72:1-3.
    Tree AC; Siva S; Ost P
    Eur Urol; 2017 Sep; 72(3):e66-e67. PubMed ID: 28642019
    [No Abstract]   [Full Text] [Related]  

  • 13. Re: Joaquin Mateo, Karim Fizazi, Silke Gillessen, et al. Managing Nonmetastatic Castration-resistant Prostate Cancer. Eur Urol 2019:75:285-93.
    von Eyben FE; Bauman G
    Eur Urol; 2020 Mar; 77(3):e67-e68. PubMed ID: 31300234
    [No Abstract]   [Full Text] [Related]  

  • 14. Re: Joaquin Mateo, Karim Fizazi, Silke Gillessen, et al. Managing Nonmetastatic Castration-resistant Prostate Cancer. Eur Urol 2019;75:285-93.
    Rocco B; Sighinolfi MC
    Eur Urol; 2020 Mar; 77(3):e69. PubMed ID: 31151677
    [No Abstract]   [Full Text] [Related]  

  • 15. Re: Stephanie Guillaumier, Max Peters, Manit Arya, et al. A Multicentre Study of 5-year Outcomes Following Focal Therapy in Treating Clinically Significant Nonmetastatic Prostate Cancer. Eur Urol 2018;74:422-9.
    Zhou Z; Zhou Y; Yan W
    Eur Urol; 2019 Apr; 75(4):e114. PubMed ID: 30502103
    [No Abstract]   [Full Text] [Related]  

  • 16. Reply to Lu Yang, Shi Qiu and Qiang Wei's Letter to the Editor re: Christopher E. Bayne, Stephen B. Williams, Matthew R. Cooperberg, et al. Treatment of the Primary Tumor in Metastatic Prostate Cancer: Current Concepts and Future Perspectives. Eur Urol 2016;69:775-87.
    Bayne CE; Williams -B; Chapin BF
    Eur Urol; 2017 Feb; 71(2):e51. PubMed ID: 27461403
    [No Abstract]   [Full Text] [Related]  

  • 17. The eternal enigma in prostatic biopsy access route.
    Fabiani A; Principi E; Filosa A; Servi L
    Arch Ital Urol Androl; 2017 Oct; 89(3):245-246. PubMed ID: 28969413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re: Monique J. Roobol, Ewout W. Steyerberg, Ries Kranse, et al. A risk-based strategy improves prostate-specific antigen-driven detection of prostate cancer. Eur Urol 2010;57:79-85.
    Morrod D
    Eur Urol; 2010 Sep; 58(3):327; author reply 328-30. PubMed ID: 20598799
    [No Abstract]   [Full Text] [Related]  

  • 19. Response to Claire Vale, David Fisher, Jayne Tierney, Ian White, Matthew Sydes, and James Carpenter's Letter to the Editor re: Christopher J.D. Wallis, Zachary Klaassen, Bimal Bhindi, et al. Comparison of Abiraterone Acetate and Docetaxel with Androgen Deprivation Therapy in High-risk and Metastatic Hormone-naïve Prostate Cancer: A Systematic Review and Network Meta-analysis. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2017.10.002.
    Wallis CJD; Klaassen Z
    Eur Urol; 2018 Mar; 73(3):e51. PubMed ID: 29224912
    [No Abstract]   [Full Text] [Related]  

  • 20. Re: Jeffrey J. Tosoian, Debasish Sundi, Bruce J. Trock, et al. Pathologic Outcomes in Favorable-risk Prostate Cancer: Comparative Analysis of Men Electing Active Surveillance and Immediate Surgery. Eur Urol 2016;69:576-81.
    Yan W; Zhou Z; Li H
    Eur Urol; 2017 Jan; 71(1):e12. PubMed ID: 27262630
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.